Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Joris Troubleyn
Drotrecogin Alfa (Activated) May Attenuate Severe Sepsis-Associated Encephalopathy in Clinical Septic Shock
Critical Care
Critical Care
Intensive Care Medicine
Related publications
Introduction: Severe Sepsis and Drotrecogin Alfa (Activated)
Critical Care
Critical Care
Intensive Care Medicine
Drotrecogin Alfa Activated as a Treatment for Severe Sepsis in Pediatric Cancer
Bone Marrow Transplantation
Transplantation
Hematology
Drotrecogin Alfa (Activated)
European Journal of Anaesthesiology
Anesthesiology
Pain Medicine
Sepsis Bundle Adherence Is Associated With Improved Survival in Severe Sepsis or Septic Shock
Western Journal of Emergency Medicine
Medicine
Emergency Medicine
Sepsis, Severe Sepsis and Septic Shock in Adults and Anaesthesia
Southern African Journal of Anaesthesia and Analgesia
Anesthesiology
Pain Medicine
The Safety Profile of Drotrecogin Alfa (Activated)
Critical Care
Critical Care
Intensive Care Medicine
Sepsis, Severe Sepsis and Septic Shock: Changes in Incidence, Pathogens and Outcomes
Expert Review of Anti-Infective Therapy
Virology
Infectious Diseases
Microbiology
Drotrecogin Alfa in Patients With Severe Sepsis: Experience From a Tertiary Care Center in North India
Critical Care
Critical Care
Intensive Care Medicine
Diagnosis of Adrenal Insufficiency in Severe Sepsis and Septic Shock
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
